A Phase 1/2 Study of VX-670 in Adult Participants With Myotonic Dystrophy 1 (DM1)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
The purpose of the study is to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of VX-670 at different single and multiple doses in participants with DM1.
Epistemonikos ID: eff959afe051ed2ad293756c90ddabf0aefa6a04
First added on: May 15, 2024